Back | Next |
home / stock / trvn / trvn message board
Subject | By | Source | When |
---|---|---|---|
ZERO BORROW now,no more shares to short | 81vette | investorshub | 05/08/2023 2:20:03 PM |
What's the float | Imarket13 | investorshub | 05/08/2023 2:15:47 PM |
average days of run,(7)on news,and this is best | 81vette | investorshub | 05/08/2023 2:13:36 PM |
price $5-$20 analyst target,float 7m.shares outstanding 9m | 81vette | investorshub | 05/08/2023 2:04:17 PM |
https://finance.yahoo.com/news/trevena-announces-approval-olinvyk-china-11000029 | 81vette | investorshub | 05/08/2023 1:58:00 PM |
maybe to let the crooks do what they | madras50 | investorshub | 05/08/2023 1:57:19 PM |
$TRVN: Interesting play here. | Invest-in-America | investorshub | 05/08/2023 1:56:19 PM |
Looks like we got halted. Wonder why. | Majobuki | investorshub | 05/08/2023 1:50:43 PM |
Could be interesting......... | Pioneer10257 | investorshub | 05/08/2023 1:19:17 PM |
is it bear time? Or do we go bull? | longboarder7892 | investorshub | 05/05/2023 5:25:40 PM |
$TRVN is it bear time? Or do we go bull? | ChillingPenguin | investorshub | 05/04/2023 7:29:35 PM |
Anyone hear anything lately? Want to see this one go | longboarder7892 | investorshub | 05/02/2023 12:01:15 AM |
Price gaining | kijia | investorshub | 05/01/2023 8:55:56 AM |
$TRVN Have a look at this | longboarder7892 | investorshub | 04/30/2023 6:21:14 PM |
must see | WindowCleaner4Life | investorshub | 04/29/2023 3:05:06 PM |
Price trading | 81vette | investorshub | 04/29/2023 1:56:51 PM |
$TRVN good read | senderos | investorshub | 04/28/2023 3:38:07 AM |
$TRVN The trading last trade up | senderos | investorshub | 04/28/2023 2:10:25 AM |
MomentumIts now up | longboarder7892 | investorshub | 04/27/2023 5:04:34 AM |
$TRVN are we finally gonna see some action | GoodGuyBill | investorshub | 04/27/2023 4:06:01 AM |
News, Short Squeeze, Breakout and More Instantly...
2024-04-02 07:15:05 ET JMP Securities analyst issues MARKET OUTPERFORM recommendation for TRVN on April 2, 2024 05:40AM ET. The previous analyst recommendation was Market Outperform. TRVN was trading at $0.4 at issue of the analyst recommendation. Historical Analyst Re...
TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important milestones in both non-clinical and clinical studies Company announces reduction of OLINVYK commercial support and review of alternatives for OLINVYK CHESTERBROOK, Pa., April 01, 2024 (GL...
CHESTERBROOK, Pa., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Trevena, Inc. ("Trevena" or the "Company") (NASDAQ:TRVN), a biopharmaceutical company focus...